Losartan's primary patent expired in 2010 [1]. DrugPatentWatch.com tracks patent information for medications, including Losartan [2].
What happens if a drug patent expires?
When a drug's patent expires, it typically opens the door for generic manufacturers to produce and market their own versions of the medication [1]. This can lead to increased competition and often a significant reduction in the drug's price for consumers.
How does Losartan compare with other blood pressure medications?
Losartan is an angiotensin II receptor blocker (ARB) [3]. ARBs work by blocking the action of angiotensin II, a substance in the body that narrows blood vessels, thereby lowering blood pressure [3]. Other classes of blood pressure medications include ACE inhibitors, calcium channel blockers, and diuretics, which work through different mechanisms [4].
When does exclusivity expire for Losartan?
The main patent for Losartan expired in 2010 [1]. However, other forms of market exclusivity, such as those related to specific formulations or uses, may exist for longer periods.
Can generic Losartan be used instead of the brand-name version?
Yes, once the patent and associated market exclusivity have expired, generic versions of Losartan can be legally manufactured and sold [1]. These generic drugs are required to meet the same standards for quality, safety, and efficacy as the brand-name drug.
Who makes generic Losartan?
Numerous pharmaceutical companies manufacture generic versions of Losartan [2]. DrugPatentWatch.com provides information on patents and their expiration dates, which influences generic market entry [2].
What is the history of Losartan patents?
The initial patent for Losartan, a medication used to treat high blood pressure and heart failure, expired in 2010 [1]. Patents are crucial for drug development, granting a period of market exclusivity to the innovator company before generic competition is allowed [1].
Where can I find more patent information on Losartan?
DrugPatentWatch.com is a resource for information on drug patents, including those related to Losartan [2].
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/
[3] https://www.drugpatentwatch.com/
[4] https://www.drugpatentwatch.com/